NEWS: 公告在東京證券交易所JASDAQ標準市場新上市


醫藥品有效成分 (API)的全球市場

Global Active Pharmaceuticals Ingredients Market 2019-2026

出版商 DataM Intelligence 商品編碼 792794
出版日期 按訂單生產 內容資訊 英文
商品交期: 請詢問到貨日
醫藥品有效成分 (API)的全球市場 Global Active Pharmaceuticals Ingredients Market 2019-2026
出版日期: 按訂單生產內容資訊: 英文

本報告提供全球醫藥品有效成分 (API) 市場相關調查分析,提供產業分析,市場分析,各地區分析,競爭情形,主要企業等相關的系統性資訊。

第1章 調查手法·範圍

第2章 全球醫藥品有效成分 (API) 市場:趨勢

  • 主要趨勢與發展

第3章 全球醫藥品有效成分 (API) 市場:產業分析

  • 對產業的影響要素 (促進因素·阻礙因素)
  • 競爭的集中度:波特的五力分析
  • 法規分析

第4章 全球醫藥品有效成分 (API) 市場:市場分析

  • 各類型
    • 合成API
    • 生物科技API
  • 各性質
    • 非專利API
    • 劃時代的API
  • 製造類別
    • 專屬式
    • 商人
  • 各用途
    • 心血管
    • 糖尿病
    • 腫瘤
    • 整形外科
    • 神經學
    • NSAIDS
    • 其他

第5章 全球醫藥品有效成分 (API) 市場:地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 其他

第6章 全球醫藥品有效成分 (API) 市場:競爭情形

  • 市場佔有率分析
  • 主要策略
  • 產品基準

第7章 企業簡介

  • Aurobindo Pharma
  • Mylan
  • Teva Active Pharmaceutical Ingredients
  • Ipca
  • Aceto Corporation
  • Arevipharma GmbH
  • Dr. Reddy's
  • Pfizer, Inc
  • Novartis International AG
  • Sanofi
  • Ranbaxy
  • Sun Pharma

第8章 附錄


Active Pharmaceutical Ingredients Market

The Active Pharmaceutical Ingredients Market Size was valued at USD xx million in 2016 and USD xx million in 2017 .

The market forecast for the year 2025 is pegged at USD xx million, with a CAGR of xx% during the period (2018-2025).

Global Active Pharmaceuticals Ingredients Market: Segmentation

The Active Pharmaceutical Ingredients Market Size is segmented based on Type, Nature, Application, and Manufacturing type.

By type, the market is divided into Synthetic API and Biotech API.

Biotech APIs include Monoclonal Antibodies, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Synthetic Immunomodulators, Vaccines, Recombinant Enzymes, Antibiotics, Statins, and Others.

By Manufacturing type, the market is divided into Captive and Merchant.

Captive API is the largest segment covering a significant part of the global API market with a market share of approximately 61% while the remaining is taken by Merchant API.

By End User, the market is classified into-Patients with chronical diseases, Physicians, Hetero Labs, Pharmaceutical companies, Hospitals, Parents/Relatives, and Others.

Based on Nature into Generic API and Innovator API.

Based on Application as Cardiovascular, Diabetes, Oncology, Orthopaedics, Neurology, NSAIDS, and Others.

The scope of the report:

This Active Pharmaceutical Ingredients Report covers factors impacting the market, Porter 5 Forces, Market Share Analysis, Price trend analysis, Product Benchmarking, and Company Profiles.

The report profiles various companies including Aurobindo Pharma, Mylan, Teva Active Pharmaceutical Ingredients, Ipca, Hetero Labs, Pharmaceutical companies Aceto Corporation, Arevipharma GmbH, Dr. Reddy's Laboratories, Pfizer, Inc, Novartis International AG, Sanofi, Ranbaxy, and Sun Pharma.

What are the key factors driving the global active pharmaceutical ingredients market?

Aurobindo Pharma has the highest Active Pharmaceutical Ingredients Market Share.

Patent expiration of a drug leads to its generic version and the manufacturers bear the cost.

This decreases the overall cost of the ingredient thereby increasing the number of users, which further increases the global market for the parts.

For instance, the patent for Teva's long-acting MS med Copaxone 40 mg, which has a revenue of $3.48 billion in the U.S. expired allowing the manufacturers to use the technology and produce the drug leading to an increase in production from 80% to 85%.

Patent expiries of the branded drugs, increased uptake of biologics, government initiatives for biomedical research are majorly driving the global Active Pharmaceutical Ingredients Market. However, Unfavourable Drug Price Control Policies Across Various Countries is holding back the growth of the market.

Regional Insights:

The report segments the geographies by region, which include North America, South America, Europe, Asia Pacific, and RoW.

North America dominates the Global Active Pharmaceutical Ingredients Market with a share of approximately 40.1%, followed by Europe with 24%.

Increasing medical requirements, advancement in R&D and innovations in this regions are favoring the growth of the market.

Why purchase the Active Pharmaceutical Ingredients Report?

Visualization of Active Pharmaceutical Ingredients Market composition across each indication, regarding type and applications, highlighting the critical commercial assets and players.

Identification of commercial opportunities in Active Pharmaceutical Ingredients by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of market level 4/5 segmentation

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study

Product mapping in excel for crucial products of all major market players

Table of Contents

Chapter 1 Global Active Pharmaceutical Ingredients Market: Methodology and Scope

  • 1.1 Research methodology
  • 1.2 Scope of the Report

Chapter 2 Global Active Pharmaceutical Ingredients Market-Trends

  • 2.1 Key Trends & Developments

Chapter 3 Global Active Pharmaceutical Ingredients Market-Industry Analysis

  • 3.1 Industry Impact Factors (Drivers & Restraints)
  • 3.2 Competitive Intensity- Porter 5 Forces
  • 3.3 Regulatory Analysis

Chapter 4 Global Active Pharmaceutical Ingredients Market-Market Analysis

  • 4.1. Active Pharmaceutical Ingredients Market By Type
    • 4.1.1. Synthetic API
    • 4.1.2. Biotech API
  • 4.2. Active Pharmaceutical Ingredients Market- By Nature
    • 4.2.1. Generic API
    • 4.2.2. Innovator API
  • 4.3. Active Pharmaceutical Ingredients Market- By Manufacturing type
    • 4.3.1. Captive
    • 4.3.2. Merchant
  • 4.4. Active Pharmaceutical Ingredients Market- By Application
    • 4.4.1. Cardiovascular
    • 4.4.2. Diabetes
    • 4.4.3. Oncology
    • 4.4.4. Orthopaedics
    • 4.4.5. Neurology
    • 4.4.6. NSAIDS
    • 4.4.7. Others

Chapter 5 Global Active Pharmaceutical Ingredients Market-Geographical Analysis

  • 5.1. North America
    • 5.1.1. The USA
    • 5.1.2. Canada
    • 5.1.3. Mexico
  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. The UK
    • 5.2.4. Italy
    • 5.2.5. Spain
    • 5.2.6. Rest of Europe
  • 5.3. Asia Pacific
    • 5.3.1. China
    • 5.3.2. Japan
    • 5.3.3. India
    • 5.3.4. Australia
    • 5.3.5. Rest of Asia Pacific
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
    • 5.4.3. Rest of South America
  • 5.5. RoW

Chapter 6 Global Active Pharmaceutical Ingredients Market-Competitive Landscape

  • 6.1. Market Share Analysis
  • 6.2. Key Strategies
  • 6.3. Product Benchmarking

Chapter 7 Global Active Pharmaceutical Ingredients Market-Company Profiles

  • 7.1. Aurobindo Pharma
  • 7.2. Mylan
  • 7.3. Teva Active Pharmaceutical Ingredients
  • 7.4. Ipca
  • 7.5. Aceto Corporation
  • 7.6. Arevipharma GmbH
  • 7.7. Dr. Reddy’s
  • 7.8. Pfizer, Inc
  • 7.9. Novartis International AG
  • 7.10. Sanofi
  • 7.11. Ranbaxy
  • 7.12. Sun Pharma

8. Appendix

  • 8.1 Sources
  • 8.2 List of Tables
  • 8.3 Expert Panel Validation
  • 8.4 Disclaimer
  • 8.5 Contact Us